FDG-PET is a considerably better predictor of treatment response and outcome than fluoride-PET for breast cancer patients with metastatic bone lesions, concluded researchers on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference. {read more here}